INIS
anticoagulants
66%
comparative evaluations
100%
concentration
50%
control
100%
detection
16%
doses
16%
evaluation
16%
levels
16%
patients
100%
performance
100%
progestin
10%
prothrombin
100%
sensitivity
16%
thromboplastin
50%
wave forms
100%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
25%
Activated Protein C Resistance
100%
Anticoagulant Agent
28%
Clotting Time
42%
Direct Oral Anticoagulant
28%
Edoxaban
100%
Epileptic Absence
12%
Fibrinolytic Agent
28%
Hormone Cancer Therapy
12%
Normal Human
12%
Oral Contraceptive
12%
Oral Contraceptive Agent
37%
Progestin
12%
Prothrombin
85%
Thromboplastin
42%
Vein Thrombosis
12%
Keyphrases
Assay Design
12%
Clot Waveform
14%
Coagulation Abnormalities
12%
Coagulation Kinetics
25%
Coagulometer
14%
Fibrinolytic System
14%
Hormonal Contraception
12%
Progestin-only pill
12%
Proteolysis Targeting chimera (PROTAC)
25%
Waveform Parameters
14%
Weak Predictors
14%